Hiroki Yasui
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Lung Cancer Treatments and Mutations 3
- Oncology 12
- Cancer Cells and Metastasis 6
- HER2/EGFR in Cancer Research 4
- Peptidase Inhibition and Analysis 3
- Co-authors
- Yuichi Ohnishi (11 shared papers)Masami Nozaki (6 shared papers)Osamu Taguchi (10 shared papers)Esteban C. Gabazza (10 shared papers)Yukihiko Adachi (7 shared papers)Tetsu Kobayashi (9 shared papers)Hiromichi Ueda (2 shared papers)Koji Suzuki (5 shared papers)
- Journals
- American Journal of Respiratory and Critical Care Medicine (4 papers)Oncology Reports (3 papers)Heart and Vessels (2 papers)Cancer (1 paper)Scientific Reports (1 paper)
- Partner nations
- JapanFinlandUnited Kingdom
In The Last Decade
Hiroki Yasui
31 papers receiving 1.0k citations
Hiroki Yasui's Hit Papers
Peers
Comparison fields: 5 of 92
- Internal Medicine 54
- Hematology 139
- Epidemiology 416
- Physiology 37
- Geriatrics and Gerontology 31
Countries citing papers authored by Hiroki Yasui
This map shows the geographic impact of Hiroki Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Yasui more than expected).
Fields of papers citing papers by Hiroki Yasui
This network shows the impact of papers produced by Hiroki Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Yasui. The network helps show where Hiroki Yasui may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Yasui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation Hit paper breakdown → | 2015 | 390 |
| 2 | 2001 | 116 | |
| 3 | 2003 | 63 | |
| 4 | 1998 | 57 | |
| 5 | 2013 | 47 | |
| 6 | 2020 | 40 | |
| 7 | 2016 | 39 | |
| 8 | 1999 | 32 | |
| 9 | 2015 | 28 | |
| 10 | 2000 | 25 | |
| 11 | 2016 | 22 | |
| 12 | 2017 | 17 | |
| 13 | 2017 | 17 | |
| 14 | 2000 | 16 | |
| 15 | 2016 | 14 | |
| 16 | 2015 | 14 | |
| 17 | 2019 | 14 | |
| 18 | 2017 | 12 | |
| 19 | 1997 | 11 | |
| 20 | 2001 | 10 |
About Hiroki Yasui
Hiroki Yasui is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Hematology and Surgery, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), HER2/EGFR in Cancer Research (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Internal Medicine (54 citations), Hematology (139 citations), Epidemiology (416 citations), Physiology (37 citations) and Geriatrics and Gerontology (31 citations). Hiroki Yasui has collaborated with scholars based in Japan, Finland and United Kingdom. Frequent co-authors include Yuichi Ohnishi, Masami Nozaki, Osamu Taguchi, Esteban C. Gabazza, Yukihiko Adachi, Tetsu Kobayashi, Hiromichi Ueda, Koji Suzuki, Kinya Otsu and Shungo Hikoso. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, Oncology Reports, Heart and Vessels, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.